(Q36462580)

14 August 2017

1 reference

title

Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible? (English)

1 reference

14 August 2017

1 reference

1 reference

Cecile Grootscholten

1

1 reference

14 August 2017

Jo H M Berden

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

27 April 2006

1 reference

Nephrology Dialysis Transplantation

14 August 2017

published in

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

1465-1469

1 reference

Maintenance therapy for lupus nephritis--something old, something new.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Mycophenolate mofetil for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

21 January 2018

Lupus nephritis flares

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL208

21 January 2018

Identifiers

DOI

10.1093/NDT/GFL208

1 reference

14 August 2017

1 reference